KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Jul 15, 2019 $19.00 $19.20 $18.72 $18.99 628 630
Jul 12, 2019 $18.78 $19.40 $18.64 $19.00 1 061 565
Jul 11, 2019 $19.84 $19.84 $16.95 $18.51 2 427 311
Jul 10, 2019 $20.93 $21.05 $19.81 $19.89 825 178
Jul 09, 2019 $20.85 $21.13 $20.61 $20.96 322 846
Jul 08, 2019 $20.80 $21.13 $20.37 $20.90 1 159 161
Jul 05, 2019 $21.27 $21.43 $20.71 $20.78 383 472
Jul 03, 2019 $21.08 $21.51 $21.01 $21.48 191 157
Jul 02, 2019 $21.18 $21.18 $20.73 $21.04 285 243
Jul 01, 2019 $21.10 $21.31 $20.74 $21.16 608 553
Jun 28, 2019 $20.01 $20.90 $19.99 $20.82 876 392
Jun 27, 2019 $19.62 $19.92 $19.43 $19.92 346 498
Jun 26, 2019 $19.67 $19.86 $19.52 $19.62 331 498
Jun 25, 2019 $19.62 $20.04 $19.51 $19.56 281 170
Jun 24, 2019 $19.96 $20.00 $19.51 $19.57 455 296
Jun 21, 2019 $20.15 $20.23 $19.75 $20.00 655 487
Jun 20, 2019 $20.20 $20.48 $19.90 $20.24 583 817
Jun 19, 2019 $20.39 $20.47 $20.03 $20.07 312 657
Jun 18, 2019 $20.67 $20.86 $20.15 $20.20 345 752
Jun 17, 2019 $20.13 $20.56 $20.13 $20.54 514 851
Jun 14, 2019 $20.21 $20.53 $19.98 $20.00 407 844
Jun 13, 2019 $19.90 $20.22 $19.66 $20.22 363 663
Jun 12, 2019 $19.78 $20.21 $19.65 $19.78 334 427
Jun 11, 2019 $20.01 $20.02 $19.47 $19.75 244 286
Jun 10, 2019 $20.35 $20.35 $19.90 $19.90 214 835
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT